EUVIMEDEUVIMED entdecken
Crossref

Atractylodes macrocephala Koidz polysaccharide ameliorates DSS‐induced colitis in mice by regulating the gut microbiota and tryptophan metabolism

Qian-Wen Zhang, Meng-Jiao Yang, Chun-Yu Liao, Reham Taha, Qing-Yu Li, Mohammed Ismail Abdelmotalab, Si-Yu Zhao, Yan Xu, Zhen-Zhou Jiang iD, Cheng-Han Chu, Xin Huang, Chun-Hua Jiao und 1 weitere

British Journal of Pharmacology · 2025-04 · 182 (7) · 1508-1527

DOI: 10.1111/bph.17409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 12.12.2024. Verfasst von Qian-Wen Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Tryptophan, Atractylodes, Polysaccharides. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Clinical Capability Enhancement Project Medical, Clinical Capability Enhancement Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Ulcerative colitis (UC) is an idiopathic inflammatory bowel disease, and the range of current clinical treatments is not ideal. We previously found that polysaccharide of Atractylodes macrocephala Koidz (PAMK) is beneficial in DSS‐induced colitis, and we aimed to investigate the underlying mechanisms in this study. Experimental Approach PAMK was used to treat DSS‐induced colitis in mice, 16S rRNA sequencing analysis was used to detect changes in the intestinal microbiota, targeted metabolomics analysis was used to determine the content of tryptophan‐metabolizing bacteria, and western blotting was used to determine aryl hydrocarbon receptor (AhR) and pregnane X receptor (PXR) levels. Furthermore, antibiotic‐mediated depletion of gut microbiota and faecal microbiota transplantation were performed to assess the role of the gut microbiota in PAMK alleviation of colitis. Key Results PAMK treatment relieved intestinal microbiota dysbiosis in mice with colitis, contributed to the proliferation of tryptophan‐metabolizing bacteria, and increased the levels of tryptophan metabolites, resulting in a significant increase in the nuclear translocation of PXR and expression of PXR and its target genes, but not AhR. The gut microbiota is important in PAMK treatment of colitis, including in the alleviation of symptoms, inhibition of inflammation, maintenance of the integrity of the intestinal barrier, and the regulation of the Th17/Treg cell balance. Conclusion and Implications Based on our findings, we elucidate a novel mechanism by which PAMK alleviates DSS‐induced colitis and thus provides evidence to support the potential development of PAMK as a new clinical drug against UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeTryptophanAtractylodesPolysaccharidesColitisAnimalsMiceDextran SulfateMice, Inbred C57BLMaleReceptors, Aryl Hydrocarbon

Stichwörter der Autor:innen

Atractylodes macrocephala Koidz polysaccharidegut microbiotagut microbiota‐derived tryptophan metabolitespregnane X receptorulcerative colitis

Substanzen

TryptophanPolysaccharidesDextran SulfateReceptors, Aryl Hydrocarbon

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

ORCID-Profile: Zhen-Zhou Jiang

Förderung

  • National Natural Science Foundation of China
  • Clinical Capability Enhancement Project Medical
  • Clinical Capability Enhancement Project

Zitieren

APA

Zhang, Q. W., Yang, M. J., Liao, C. Y., Taha, R., Li, Q. Y., Abdelmotalab, M. I., Zhao, S. Y., Xu, Y., Jiang, Z. Z., Chu, C. H., Huang, X., Jiao, C. H., & Sun, L. X. (2025). Atractylodes macrocephala Koidz polysaccharide ameliorates DSS‐induced colitis in mice by regulating the gut microbiota and tryptophan metabolism. British Journal of Pharmacology, 182(7), 1508-1527. https://doi.org/10.1111/bph.17409

Vancouver

Zhang QW, Yang MJ, Liao CY, Taha R, Li QY, Abdelmotalab MI, et al. Atractylodes macrocephala Koidz polysaccharide ameliorates DSS‐induced colitis in mice by regulating the gut microbiota and tryptophan metabolism. British Journal of Pharmacology. 2025;182(7):1508-1527. doi:10.1111/bph.17409

BibTeX
@article{Zhang2025,
  author = {Zhang, Qian-Wen and Yang, Meng-Jiao and Liao, Chun-Yu and Taha, Reham and Li, Qing-Yu and Abdelmotalab, Mohammed Ismail and Zhao, Si-Yu and Xu, Yan and Jiang, Zhen-Zhou and Chu, Cheng-Han and Huang, Xin and Jiao, Chun-Hua and Sun, Li-Xin},
  title = {Atractylodes macrocephala Koidz polysaccharide ameliorates DSS‐induced colitis in mice by regulating the gut microbiota and tryptophan metabolism},
  journal = {British Journal of Pharmacology},
  year = {2025},
  volume = {182},
  number = {7},
  pages = {1508--1527},
  doi = {10.1111/bph.17409}
}
Kostenlos starten →